-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Dr.
Integrate new technologies into the clinic as soon as possible
However, there are still many hurdles that need to be overcome before the latest technologies can be used in the clinic: among them, they still need to be standardized or, due to the evaluation of large amounts of data or regulatory approval, new infrastructure in the clinic
In the field of precision oncology, liquid biopsy is a promising new technology that can provide information on a patient's cancer type faster and less invasively through a blood test
Initiative for cancer research in Switzerland
Advancing and implementing novel, cutting-edge technologies into precision medicine is a key focus of BCPM
Another important Bern precision oncology initiative is the Swiss Oncology and Cancer Immunology Breakthrough Platform (SOCIBP), which aims to establish a common genomic 'language' for Swiss cancer research: molecular tumor data will be presented in an understandable By way of presentation and sharing, genomic testing will be standardized across Switzerland
This research was supported by the Swiss Personalized Health Network (SPHN) SOCIBP, the Swiss Cancer Alliance, the Nuovo-Soldati Cancer Research Foundation, the ISREC Cancer Research Foundation and the Werner and Hedy Berger-Janser Foundation
Journal Reference:
Dilara Akhoundova, Mark A.